Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Ahmedabad-based pharmaceutical company of the Torrent Group focused on branded generics, with leading therapy presence in cardiovascular, CNS, gastro-intestinal and vitamins/minerals/nutrients. Key markets are India (majority of revenue, strengthened by acquisitions such as Elder's India business, Unichem's India business and Curatio), Brazil, Germany and the US. In 2025 it agreed to acquire a controlling stake in JB Chemicals & Pharmaceuticals from KKR. Revenue is driven by chronic-therapy branded prescriptions and field-force productivity.
A top-tier Indian branded-generics player, consistently ranked among the leaders in the domestic chronic segment.
Torrent Pharmaceuticals Ltd. is a constituent of NIFTY 100, NIFTY 200, NIFTY 500, NIFTY HEALTHCARE, NIFTY NEXT 50, NIFTY PHARMA. See where it sits on the market heatmap →
Consolidated annual figures taken from Torrent Pharmaceuticals Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 63.92 | 56.47 | 48.94 |
| Book value / share (₹) | 519.56 | 224.28 | 202.56 |
| Return on equity | 12.3% | 25.2% | 24.1% |
| Return on capital employed | 9.6% | 28.5% | 26.6% |
| Operating margin | 24.6% | 25.4% | 23.9% |
| Net margin | 15.3% | 16.6% | 15.4% |
| EBITDA | ₹4,559 Cr | ₹3,721 Cr | ₹3,368 Cr |
| Free cash flow | ₹2,346 Cr | ₹1,974 Cr | ₹2,833 Cr |
| Total debt | ₹14,798 Cr | ₹3,026 Cr | ₹3,938 Cr |
| Debt to equity | 0.84 | 0.40 | 0.57 |
| Interest coverage | 8.9 | 11.6 | 7.2 |
| Current ratio | 1.13 | 1.19 | 1.03 |
| Shares outstanding | 33,84,60,000 | 33,84,60,000 | 33,84,60,000 |
Open the full income statement, balance sheet and cash flow for TORNTPHARM →
As disclosed for the quarter ended 20 Jul 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.